Next Article in Journal
Highly Efficient Blue Thermally Activated Delayed Fluorescence Emitters Based on Multi-Donor Modified Oxygen-Bridged Boron Acceptor
Next Article in Special Issue
Application of COSMO-RS-DARE as a Tool for Testing Consistency of Solubility Data: Case of Coumarin in Neat Alcohols
Previous Article in Journal
Redox-Active Metal-Organic Frameworks with Three-Dimensional Lattice Containing the m-Tetrathiafulvalene-Tetrabenzoate
Previous Article in Special Issue
New Screening Protocol for Effective Green Solvents Selection of Benzamide, Salicylamide and Ethenzamide
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Solubility and Thermodynamic Data of Febuxostat in Various Mono Solvents at Different Temperatures

Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
*
Author to whom correspondence should be addressed.
Molecules 2022, 27(13), 4043; https://doi.org/10.3390/molecules27134043
Submission received: 7 June 2022 / Revised: 20 June 2022 / Accepted: 20 June 2022 / Published: 23 June 2022

Abstract

:
This study examines the solubility and thermodynamics of febuxostat (FBX) in a variety of mono solvents, including “water, methanol (MeOH), ethanol (EtOH), isopropanol (IPA), 1-butanol (1-BuOH), 2-butanol (2-BuOH), ethylene glycol (EG), propylene glycol (PG), polyethylene glycol-400 (PEG-400), ethyl acetate (EA), Transcutol-HP (THP), and dimethyl sulfoxide (DMSO)” at 298.2–318.2 K and 101.1 kPa. The solubility of FBX was determined using a shake flask method and correlated with “van’t Hoff, Buchowski-Ksiazczak λh, and Apelblat models”. The overall error values for van’t Hoff, Buchowski-Ksiazczak λh, and Apelblat models was recorded to be 1.60, 2.86, and 1.14%, respectively. The maximum mole fraction solubility of FBX was 3.06 × 10−2 in PEG-400 at 318.2 K, however the least one was 1.97 × 10−7 in water at 298.2 K. The FBX solubility increased with temperature and the order followed in different mono solvents was PEG-400 (3.06 × 10−2) > THP (1.70 × 10−2) > 2-BuOH (1.38 × 10−2) > 1-BuOH (1.37 × 10−2) > IPA (1.10 × 10−2) > EtOH (8.37 × 10−3) > EA (8.31 × 10−3) > DMSO (7.35 × 10−3) > MeOH (3.26 × 10−3) > PG (1.88 × 10−3) > EG (1.31 × 10−3) > water (1.14 × 10−6) at 318.2 K. Compared to the other combinations of FBX and mono solvents, FBX-PEG-400 had the strongest solute-solvent interactions. The apparent thermodynamic analysis revealed that FBX dissolution was “endothermic and entropy-driven” in all mono solvents investigated. Based on these findings, PEG-400 appears to be the optimal co-solvent for FBX solubility.

1. Introduction

Febuxostat (FBX) (molecular structure: Figure 1; IUPAC name: 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid) occurs as a white crystalline powder [1,2]. It is a selective nonpurine inhibitor of xanthine oxidoreductase [3]. It has been recommended for the treatment of hyperuricemia in adults with gout [3,4]. Polymorphism is one of the characteristics of FBX [5]. Three polymorphs (form A, B, and C) and two solvates (BH and D) are among the five distinct forms of FBX [6,7,8]. The most preferred forms of FBX is form A and its crystallization process is difficult to control [7]. A novel crystalline form of FBX (form H) has been identified that has been demonstrated to be stable under a variety of circumstances and is ideal for dosage form design [1].
FBX is a biopharmaceutical classification system (BCS) class II drug with poor solubility in aqueous media and high permeability [2]. Its solubility in water is very poor, which is the main hurdle for its formulation development [9]. The solubility and physicochemical data of FBX are poorly reported in literature [1,9]. The solubility data, solubility parameters, and thermodynamic properties of poorly water-soluble compounds in aqueous and organic solvents are important for various industrial applications [10,11,12,13]. The solubility of FBX in water at 310.2 K has been reported [9]. The solubility of FBX in four different organic solvents such as methanol (MeOH), ethanol (EtOH), acetone, and ethyl acetate (EA) at 293.15–328.15 K and 101.1 kPa has been reported well in the literature [1].
Other researched mono solvents such as isopropanol (IPA), 1-butanol (1-BuOH), 2-butanol (2-BuOH), ethylene glycol (EG), propylene glycol (PG), polyethylene glycol-400 (PEG-400), Transcutol-HP (THP), and dimethyl sulfoxide (DMSO) have not had their solubility and other physicochemical data published. As a result, new solubility and physicochemical data for FBX in various mono solvents, including water, MeOH, EtOH, IPA, 1-BuOH, 2-BuOH, EG, PG, PEG-400, THP, EA, and DMSO at 298.2–318.2 K and 101.1 kPa, are reported in this study. “Apparent thermodynamic analysis” was carried out to evaluate the dissolution behavior of FBX in various mono solvents. The solubility and physicochemical data of FBX obtained in this research could be used in “purification, recrystallization, drug discovery, pre-formulation studies, and formulation development” of FBX.

2. Materials and Methods

2.1. Materials and Reagents

The FBX (form H) standard drug was procured from “E-Merck (Darmstadt, Germany)”. EG, PG, PEG-400, EA, and DMSO were procured from “Sigma Aldrich (St. Louis, MO, USA)”. MeOH, EtOH, IPA, 1-BuOH, and 2-BuOH were obtained from “E-Merck (Darmstadt, Germany)”. The Milli-Q unit provided purified water. The details about each material are summarized in Supplementary Table S1.

2.2. Determination of FBX Using High-Performance Liquid Chromatography (HPLC) Method

A validated HPLC method was used to analyze FBX in solubility samples. The quantitation of FBX was performed via ultra-violet (UV) detector at a wavelength of 354 nm. The entire estimation of FBX was performed at 298.2 K utilizing “HPLC system (Waters, Milford, MA, USA)”. The column “Nucleodur (150 × 4.6 mm, 5 μm) reverse-phase C18 column” was used for the chromatographic analysis of FBX. The binary mixture of EtOH and EA (50:50, % v/v) was used as the greener solvent system under the flow rate of 1.0 mL min−1. Prior to use, the greener solvent combination was freshly produced, filtered through nylon filter paper with a pore size of 0.45 µm, and degassed. The injection volume was set at 20 µL. The FBX calibration curve was created by plotting the FBX concentrations against the measured HPLC response. In the range of 1–100 µg g−1, the calibration plot of FBX was linear, with a determination coefficient (R2) of 0.9979. The regression line equation for FBX was y = 46,266x + 14,848; where x and y represent the FBX concentration and observed HPLC response, respectively.

2.3. Solid Phase Characterization of FBX

For pure FBX and equilibrated FBX (the solid recovered from bottom phase of equilibrated sample), Fourier transforms infrared (FTIR) spectroscopy and powder X-ray diffraction (PXRD) analyses were used to characterize the solid phases. Slow evaporation was used to recover the equilibrated FBX from water [12,13]. For FTIR analysis, the absorption spectra were obtained in the range of 300–4000 cm−1 using the potassium bromide disc technique as reported in literature [14]. For PXRD measurement, the samples were analyzed by “Ultima IV Diffractometer (Rigaku Inc., Tokyo, Japan)” equipped with “Cu–Kα radiation 1.5406 Å”. With a step size of 0.02°, both pure and equilibrated FBX samples were examined in the 2θ range of 2–60° [13]. The FTIR and PXRD analyses were used to investigate the probable transformations of FBX into other physical states, such as polymorphs, solvates, and hydrates, among others.

2.4. FBX Solubility Measurement

At 298.2–318.2 K and 101.1 kPa, the solubility of FBX in several mono solvents was measured using an experimental approach proposed by “Higuchi and Connors” [15]. The extra FBX was mixed with the known amount of each mono solvent. The obtained suspensions were vortexed for 10 min. All of the samples were shaken at 100 rpm for 72 h in a “WiseBath® WSB Shaking Water Bath (Model WSB-18/30/-45, Daihan Scientific Co., Ltd., Seoul, Korea)” [16,17]. Each sample was obtained, filtered, and centrifuged at 5000 rpm for 30 min after equilibrium was reached (equilibrium time = 72 h). The supernatant was obtained, diluted (as needed), and utilized to determine the amount of FBX in the sample using the HPLC-UV technique at a wavelength of 354 nm. The “experimental mole fraction solubility (xe)” of FBX was computed by the following equation [18,19]:
x e = m 1 / M 1 m 1 / M 1 + m 2 / M 2
where, m1 = FBX mass, m2 = solvent mass, M1 = FBX molar mass, and M2 = solvent molar mass.

2.5. Computation of Solubility Parameters

Drug compounds with similar solubility parameters could reach the maximum solubility in the sample matrices under standard conditions [20]. As a result, this study estimated different solubility parameters for FBX and several mono solvents. The following equation was used to calculate the total “Hansen solubility parameter (HSP)” of FBX [20,21,22]:
δ 2 = δ d 2 + δ p 2 + δ h 2
where, “δ = total HSP of FBX; δd = dispersion HSP of FBX; δp = polar HSP of FBX, and δh = hydrogen-bonded HSP of FBX”.
The “HSPiP software (version 4.1.07, Louisville, KY, USA)” was used to calculate the values of δ, δd, δp, and δh for FBX. These values were determined by putting the simplified molecular input line entry system (SMILES) of FBX into HSPiP software. The SMILES of FBX was taken from its PubChem data. However, the values of δ, δd, δp, and δh for various mono solvents were taken from reference [12].
The following equation was used to calculate the “van Krevelen and Hoftyzer solubility parameter (∆ δ ¯ )” [23]:
δ ¯ = δ d 2 2 δ d 1 2 + δ p 2 2 δ p 1 2 + δ h 2 2 δ h 1 2 1 / 2
Subscripts 1 and 2 denote the specific mono solvent and FBX, respectively. According to the literature if ∆ δ ¯ < 5.0 MPa1/2, the solubility of the solute in the mono solvent will be higher [23,24].
The following equation was used to compute the “three dimensional (3D) solubility parameter space (Ra)” [25,26]:
R a 2 = 4 δ d 2 δ d 1 2 + δ p 2 δ p 1 2 + δ h 2 δ h 1 2
According to literature, the solubility of FBX in mono solvent will be higher if Ra < 5.6 MPa1/2 [25].
The “Greenhalgh’s solubility parameter (∆δ)” was computed using the following equation [27]:
δ = δ 2 δ 1
According to the literature, the solubility of FBX in mono solvent will be higher if ∆δ < 7.0 MPa1/2 [21,27].

2.6. Ideal Solubility of FBX and Solute-Solvent Interactions

The following equation was used to compute an “ideal solubility (xidl)” of FBX at 298.2–318.2 K [28]:
ln   x idl = H fus T fus T R T fus T + C p R [ T fus T T + ln T T fus ]  
R is the universal gas constant, Tfus is the FBX fusion temperature, ∆Hfus is the FBX fusion enthalpy, and ∆Cp is the difference between FBX’s solid phase and liquid state molar heat capacity. The following equation was used to compute the ∆Cp for FBX [28,29]:
C p = H fus T fus
From reference [2], the Tfus and ∆Hfus values for FBX were derived as 486.53 K and 27.58 kJ mol1, respectively. Using Equation (7), the ∆Cp for FBX was estimated to be 56.68 J mol−1 K−1. Finally, using Equation (6), the xidl values for FBX were calculated.
The following equation was used to calculate the “activity coefficients (γi)” for FBX in several mono solvents at 298.2–318.2 K [28,30]:
γ i = x idl x e
Based on the computed γi values of FBX at 298.2–318.3 K, FBX-solvent molecular interactions were estimated.

2.7. FBX Solubility Correlation Using Computational Approaches

For practical validations, computational analysis of experimental solubility of solutes is critical [31,32]. As a consequence, the experimental solubility of FBX was correlated with “van’t Hoff, Buchowski-Ksiazczak λh, and Apelblat models” [21,33,34,35,36,37]. The following equation was used to calculate the “Apelblat model solubility (xApl)” of FBX [33,34]:
ln   x Apl = A + B T + C ln T
A, B, and C are the model parameters obtained from the experimental FBX solubility data reported in Table 1 using “nonlinear multivariate regression analysis” [21]. The correlation between xe and xApl values of FBX was carried out in terms of “root mean square deviation (RMSD) and R2”. The RMSD of FBX was computed using its reported equation [11].
The following equation was used to calculate the “van’t Hoff model solubility (xvan’t)” of FBX [21]:
ln   x van t = a + b T
Here, a and b are the “van’t Hoff model” parameters, which were derived using “least square approach” [37].
The following equation was used to calculate the “Buchowski-Ksiazczak λh solubility (xλh)” for FBX [35,36]:
ln   [ 1 + λ 1 x λ h x λ h ] = λ h   [ 1 T 1 T fus ]
Here, λ and h are the adjustable Buchowski-Ksiazczak λh model parameters.

2.8. Thermodynamic Evaluation

“Apparent thermodynamic analysis” was utilized to determine the thermodynamic characteristics of FBX in several mono solvents. Three different parameters, including “apparent standard enthalpy (ΔsolH0), apparent standard Gibbs energy (ΔsolG0), and apparent standard entropy (ΔsolS0)” for FBX were computed using “van’t Hoff and Krug et al. analysis” [30,38,39]. The “ΔsolH0” for FBX in various mono solvents was computed at the “mean harmonic temperature (Thm)” of 308 K utilizing “van’t Hoff analysis” using the following equation [30,39]:
ln   x e 1 T 1 T hm P = sol H 0 R
The “ΔsolH0” for FBX was derived from “van’t Hoff” plots graphed between ln xe values of FBX and 1 T 1 T hm . The van’t Hoff plots for FBX in various mono solvents are included in Figure 2.
The “ΔsolG0” for FBX dissolution in various mono solvents was also computed at Thm = 308 K utilizing “Krug et al. analysis” using the following Equation (13) [38]:
sol G 0 = R T hm × intercept                                    
Here, the intercept values for FBX in various mono solvents were derived from “van’t Hoff plots” included in Figure 2.
The following equation was used to calculate the “ΔsolS0” for FBX dissolution [30,38,39]:
                                        sol S 0 = sol H 0 sol G 0 T hm                                                                  

2.9. Statistical Evaluation

“Kruskal-Wallis analysis” was used as a statistical test, followed by “Denn’s test”. In this test, “GraphpadInstat software (San Diego, CA, USA)” was employed. A significant value was defined as a one with a p value of less than 0.05.

3. Results and Discussion

3.1. Solid Phase Characterization of FBX

Form A, form B, form C, and form H, for example, are polymorphic states of the FBX [5,6]. As a result, FTIR and PXRD spectral analysis were used to characterize the solid phase of FBX (form H) in pure and equilibrated samples recovered from water. Figure 3 depicts the FTIR spectra of pure and equilibrated FBX. Pure FBX (form H) FTIR spectra revealed several FBX characteristic peaks at various wave numbers, showing the crystalline nature of pure FBX (Figure 3A). The FTIR spectra of equilibrated FBX recovered from water also revealed identical FBX features peaks at varied wave numbers (Figure 3B), showing that equilibrated FBX is crystalline. Figure 4 depicts the PXRD spectra of pure and equilibrated FBX. The PXRD spectra of pure FBX (form H) revealed multiple crystalline peaks of FBX at different 2θ values, showing that pure FBX is crystalline (Figure 4A). The PXRD spectra of equilibrated FBX recovered from water showed identical features peaks of FBX at various 2θ values (Figure 4B), showing that equilibrated FBX is crystalline. Overall, the FTIR and PXRD spectra revealed that following equilibrium, FBX (form H) was not converted into solvates, polymorphs, or hydrates. It was also expected that FBX will also be retained crystalline in other mono solvents as the experimental conditions were similar for other mono solvents.

3.2. Measured Solubility Data of FBX

The measured solubility values of FBX in various mono solvents at 298.2–318.2 K and 101.1 kPa are summarized in Table 1. The solubility of FBX in IPA, 1-BuOH, 2-BuOH, EG, PG, PEG-400, THP, and DMSO, has yet to be determined. At 310.2 K, the saturated solubility of FBX in water was 10.8 mg L−1 (converted to 6.15 × 10−7 in mole fraction) [9]. At 310.2 K, the mole fraction solubility of FBX was not measured directly in the present study. At 310.2 K, however, the mole fraction solubility of FBX was derived from the interpolation of graph constructed between ln xe and 1/T and derived to be 6.23 × 10−7. The recorded value was closed to the reported value of FBX in water. At 298.2–318.2 K, the mole fraction solubility values of FBX in MeOH, EtOH, and EA have also been published [1]. Figure 5A–C provide a graphical comparison of observed and literature solubility values of FBX in MeOH, EtOH, and EA at 298.2–318.2 K, respectively. The data presented in Figure 5 showed good correlation of measured solubility data of FBX in MeOH, EtOH, and EA with those reported in literature [1]. These findings revealed that the experimental solubility data for FBX were in good accord with the published values [1,9].
Table 1 summarizes the findings, which show that the solubility of FBX increased considerably with increasing temperature in all mono solvents examined (p < 0.05) and was in good agreement with prior research [16,17,18]. The order of FBX solubility in different mono solvents was PEG-400 (3.06 × 10−2) > THP (1.70 × 10−2) > 2-BuOH (1.38 × 10−2) > 1-BuOH (1.37 × 10−2) > IPA (1.10 × 10−2) > EtOH (8.37 × 10−3) > EA (8.31 × 10−3) > DMSO (7.35 × 10−3) > MeOH (3.26 × 10−3) > PG (1.88 × 10−3) > EG (1.31 × 10−3) > water (1.14 × 10−6) at 318.2 K. Since PEG-400 has the maximum solubility of FBX compared to the other mono solvents tested, it may be the optimal solvent for FBX solubility.

3.3. Determination of HSPs

Different HSPs for FBX were determined using “HSPiP software”. The HSPs of different mono solvents were derived from reference [12]. The values of HSPs are summarized in Table 2. FBX was found to have a δ value of 21.70 MPa1/2, indicating that it had a low polarity. Seven mono solvents such as IPA (δ = 22.30 MPa1/2), 1-BuOH (δ = 22.90 MPa1/2), 2-BuOH (δ = 20.80 MPa1/2), EA (δ = 18.10 MPa1/2), 1-DMSO (δ = 23.60 MPa1/2), THP (δ = 21.40 MPa1/2), and PEG-400 (δ = 18.90 MPa1/2) were discovered to exhibit similar δ values (lower polarities) and acceptable for FBX solubility. Water had a δ value of 47.80 MPa1/2, indicating that it was not suited for FBX solubility due to its greater polarity. It was discovered that if ∆ δ ¯ is <5.0 MPa1/2, the biomolecule’s solubility in the particular solvent will be greater [23,24]. The ∆ δ ¯ value was found to be ≥5.0 MPa1/2 in all mono solvents investigated, showing that FBX is insoluble in all mono solvents according to this idea. It has also been discovered that if the value of Ra is <5.6 MPa1/2 the biomolecule’s solubility in the particular solvent will be greater [25,26]. The Ra values in three mono solvents, EA (Ra = 7.37 MPa1/2), THP (Ra = 7.81 MPa1/2), and DMSO (Ra = 7.97 MPa1/2), were found to be closed with 5.6 MPa1/2, showing that FBX is soluble in EA, THP, and DMSO according to this idea. However, the Ra values in other mono solvents were found to be much higher than 5.6 MPa1/2, indicating the insolubility of FBX in other mono solvents according to this concept. According to the Greenhalgh’s theory, the solubility of the biomolecule in the particular solvent will be higher if ∆δ is <7.0 MPa1/2. However, the value of ∆δ > 10.0 MPa1/2 has been proposed for the insolubility of biomolecule [27]. The ∆δ value was determined to be maximum in water (∆δ = 26.10 MPa1/2), indicating the complete insolubility of FBX in water. While, the ∆δ value was determined to be lower in THP (∆δ = 0.30 MPa1/2), IPA (∆δ = 0.60 MPa1/2), 2-BuOH (∆δ = 1.10 MPa1/2), 1-BuOH (∆δ = 1.20 MPa1/2), DMSO (∆δ = 1.90 MPa1/2), PEG-400 (∆δ = 2.80 MPa1/2), EA (∆δ = 3.60 MPa1/2), and EtOH (∆δ = 3.70 MPa1/2), indicating the complete solubility of FBX in all of these mono solvents according to this concept [27].

3.4. Determination of Solute-Solvent Interactions

Table 1 summarizes the xidl values for FBX. At 298.2–318.2 K, the xidl values for FBX were found to be 3.55 × 10−2 to 5.52 × 10−2. For FBX, the xidl values were found to be substantially greater than the xe values in water (p < 0.05). The xidl values of FBX, on the other hand, were found to be near to its xe values in PEG-400. PEG-400 was shown to be appropriate for the solubility of FBX based on these findings. The γi values for FBX in different mono solvents at 298.2–318.2 K are summarized in Table 3. Compared to other mono solvents examined, the γi values for FBX were found to be substantially greater in water. With increasing temperature, the γi values of FBX in the mono solvents examined decreased significantly (p < 0.05). The γi values for FBX were found to be low in PEG-400, THP, and EA. Based on these results, the maximum solute-solvent interactions were observed in FBX-PEG-400, FBX-THP, and FBX-EA compared to other FBX-solvent combination.

3.5. FBX Solubility Correlation Using Computational Approaches

Three computational models namely, “van’t Hoff, Apelblat, and Buchowski-Ksiazaczak λh models” were employed to link FBX experimental solubility data in this study [21,33,34,35,36,37]. Figure 6 shows the data for the graphical correlation between xe and xApl values of FBX in several mono solvents against 1/T, which showed a high correlation between the xe and xApl data of FBX in several mono solvents. The results of Apelblat model computation are included in Table 4. The overall RMSD for FBX was determined to be 1.14%. R2 values for FBX in various mono solvents range from 0.9919 to 0.9999. The low RMSD values and higher R2 values revealed that the experimental solubility data of FBX in the mono solvents was well correlated with the Apelblat model.
Figure S1 shows the data for the graphical correlation between xe and xvan’t values of FBX in several mono solvents against 1/T, which also showed a high correlation between xe and xvan’t values of FBX in all mono solvents. The results for the van’t Hoff model computation for FBX in various mono solvents are summarized in Table 5. The overall RMSD for FBX in various mono solvents was determined to be 1.60%. R2 values for FBX in several mono solvents range from 0.9920 to 0.9998. The low RMSD values and higher R2 values again revealed that the experimental solubility data of FBX in mono solvents was well correlated with “van’t Hoff model”.
Table 6 summarizes the findings of the Buchowski-Ksiazaczak λh computation for FBX in numerous mono solvents. In numerous mono solvents, the overall RMSD for FBX was found to be 2.86%. The low RMSD values again showed a high correlation of experimental solubility data of FBX in numerous mono solvents with “Buchowski-Ksiazaczak λh model”. Overall, all three computational models performed well in the solubility correlation of FBX.

3.6. Apparent Thermodynamic Studies

The ΔsolH0 values for FBX in various mono solvents were determined from the van’t Hoff graphs, included in Figure 2. The results of apparent thermodynamic studies of FBX in various mono solvents are listed in Table 7. The FBX ΔsolH values in numerous mono solvents recorded as positive values in the range of 24.50–68.79 kJ mol−1. The FBX ΔsolG0 values in numerous mono solvents were also recorded positive values in the range of 10.38–37.21 kJ mol−1. The FBX ΔsolG0 values were found to be lowest in PEG-400 and highest in water, which could be attributed to FBX solubility being highest in PEG-400 and lowest in water, respectively. The positive values of ΔsolH0 for FBX suggested that FBX dissolution was an endothermic in the mono solvents examined [40,41]. The FBX ΔsolS0 values in numerous mono solvents were also recorded as positive values in the range of 37.30–157.6 J mol−1 K−1, suggesting an entropy-driven FBX dissolution in all mono solvents examined [40]. Based on the positive values of ΔsolH and ΔsolS0, the FBX dissolution was considered to be an endothermic and entropy-driven in all mono solvents examined [40,41].

4. Conclusions

The solubility values, HSPs, and thermodynamics properties of FBX in various mono solvents were investigated. FTIR and PXRD spectral analyses validated the solid state form of FBX, which revealed no alteration of FBX after equilibrium. The results on FBX solubility was strongly associated with the “van’t Hoff, Apelblat, and Buchowski-Ksiazczak λh models”. The solubility of FBX increased with increasing temperature in all mono solvents examined. The order of solubility of FBX in various mono solvents was PEG-400 > THP > 2-BuOH > 1-BuOH > IPA > EtOH > EA > DMSO > MeOH > PG > EG > water at 318.2 K. When comparing FBX-PEG-400, FBX-THP, and FBX-EA to other combinations of FBX and mono solvent, the findings of activity coefficients showed that FBX-PEG-400, FBX-THP, and FBX-EA had the most molecular interactions. Thermodynamic study indicated an “endothermic and entropy-driven dissolution” of FBX in all mono solvents examined. Based on overall results, PEG-400 has been selected as the best cosolvent for the solubility of FBX. As a consequence, PEG-400 can be used as a potential co-solvent in pre-formulation studies and formulation development of FBX.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules27134043/s1. Figure S1: Correlation of experimental solubilities of FBX with “van’t Hoff model” in different mono solvents as a function of 1/T; symbols represent the experimental solubility values of FBX and the solid lines represent the solubility data calculated by “van’t Hoff model”; Table S1: List of materials.

Author Contributions

Conceptualization, N.H. and F.S.; methodology, S.A. and A.F.A.; software, A.F.A.; validation, S.A. and A.F.A.; formal analysis, A.F.A.; investigation, N.H. and F.S.; resources, S.A.; data curation, S.A.; writing—original draft preparation, F.S.; writing—review and editing, A.F.A. and S.A.; visualization, S.A.; supervision, F.S.; project administration, F.S.; funding acquisition, S.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research project was supported by Researchers Supporting Project number (RSP-2021/146), King Saud University, Riyadh, Saudi Arabia and APC was supported by the RSP.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

This study did not report any data.

Acknowledgments

Authors are thankful to the Researchers Supporting Project number (RSP-2021/146), King Saud University, Riyadh, Saudi Arabia for supporting this work.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds FBX are available from the authors.

References

  1. Zhang, L.; Huang, Z.; Wan, X.; Li, J.; Liu, J. Measurement and correlation of the solubility of febuxostat in four organic solvents at various temperatures. J. Chem. Eng. Data 2012, 57, 3149–3152. [Google Scholar] [CrossRef]
  2. Patel, J.; Jagia, M.; Bansal, A.K.; Patel, S. Characterization and thermodynamic relationship of three polymorphs of a xanthine oxidase inhibitor, febuxostat. J. Pharm. Sci. 2015, 104, 3722–3730. [Google Scholar] [CrossRef] [PubMed]
  3. Becker, M.A.; Schumacher, H.R., Jr.; Wortmann, R.L.; Macdonald, P.A.; Eustace, D.; Palo, W.A.; Streit, J.; Joseph-Ridge, N. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N. Engl. J. Med. 2005, 353, 2450–2461. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Schumacher, H.R., Jr.; Becker, M.A.; Wortmann, R.L.; Macdonald, P.A.; Hunt, B.; Streit, J.; Lademacher, C.; Joseph-Ridge, N. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase III, randomized, double-blind, parallel-group trial. Arthritis Rheum. 2008, 59, 1540–1548. [Google Scholar] [CrossRef]
  5. Kitamura, M. Controlling factors and mechanism of polymorphic crystallization. Cryst. Growth Des. 2004, 4, 1153–1159. [Google Scholar] [CrossRef]
  6. Kitamura, M.; Hironaka, S. Effect of temperature on antisolvent crystallization and transformation behaviors of thiazole-derivative polymorphs. Cryst. Growth Des. 2006, 6, 1214–1218. [Google Scholar] [CrossRef]
  7. Kitamura, M.; Sugimoto, M. Anti-solvent crystallization and transformation of thiazole-derivative polymorphs-I: Effect of addition rate and initial concentrations. J. Cryst. Growth 2003, 257, 177–184. [Google Scholar] [CrossRef]
  8. Kitamura, M. Strategy for control of crystallization of polymorphs. CrystEngComm 2009, 11, 949–964. [Google Scholar] [CrossRef]
  9. Zhang, X.-R.; Zhang, L. Simultaneous enhancement of solubility and dissolution of rate of poorly water-soluble febuxostat via salts. J. Mol. Struct. 2017, 1137, 328–334. [Google Scholar] [CrossRef]
  10. Dadmand, S.; Kamari, F.; Acree, W.E., Jr.; Jouyban, A. Solubility prediction of drugs in binary solvent mixtures at various temperatures using a minimum number of experimental data points. AAPS PharmSciTech 2018, 20, 10. [Google Scholar] [CrossRef]
  11. Razaei, H.; Rahimpour, E.; Zhao, H.; Martinez, F.; Barzegar-Jalali, M.; Jouyban, A. Solubility of baclofen in some neat and mixed solvents at different temperatures. J. Mol. Liq. 2022, 347, 118352. [Google Scholar] [CrossRef]
  12. Shakeel, F.; Haq, N.; Alsarra, I.A. Equilibrium solubility determination, Hansen solubility parameters and solution thermodynamics of cabozantinib malate in different monosolvents of pharmaceutical importance. J. Mol. Liq. 2021, 324, 115146. [Google Scholar] [CrossRef]
  13. Ahad, A.; Shakeel, F.; Raish, M.; Ahmad, A.; Jardan, Y.A.B.; Al-Jenoobi, F.I.; Al-Mohizea, A.M. Thermodynamic solubility profile of temozolomide in different commonly used pharmaceutical solvents. Molecules 2022, 27, 1437. [Google Scholar] [CrossRef] [PubMed]
  14. Ahad, A.; Shakeel, F.; Raish, M.; Al-Jenoobi, F.I.; Al-Mohizea, A.M. Solubility and thermodynamic analysis of antihypertensive agent nitrendipine in different pure solvents at the temperature range of 298.15 to 318.15 K. APPS PharmSciTech 2017, 18, 2737–2743. [Google Scholar] [CrossRef] [PubMed]
  15. Higuchi, T.; Connors, K.A. Phase-solubility techniques. Adv. Anal. Chem. Instr. 1965, 4, 117–122. [Google Scholar]
  16. Ortiz, C.P.; Cardenas-Torres, R.E.; Martinez, F.; Delgado, D.R. Solubility of sulfamethazine in the binary mixture of acetonitrile + methanol from 278.15 to 318.15 K: Measurement, dissolution thermodynamics, preferential solvation, and correlation. Molecules 2021, 26, 7588. [Google Scholar] [CrossRef]
  17. Shen, J.; Liang, X.; Lei, H. Measurements, thermodynamic modeling, and a hydrogen bonding study on the solubilities of metoprolol succinate in organic solvents. Molecules 2018, 23, 2469. [Google Scholar] [CrossRef] [Green Version]
  18. Al-Shdefat, R. Solubility determination and solution thermodynamics of olmesartan medoxomil in (PEG-400 + water) cosolvent mixtures. Drug Dev. Ind. Pharm. 2020, 46, 2098–2104. [Google Scholar] [CrossRef]
  19. Chong, Y.; Liu, Q.; Wang, Z.; Zhu, L.; Guo, F.; Li, Y.; Li, T.; Ren, B. Solubility, MD simulation, thermodynamic properties and solvent effect of perphenazine (Form I) in eleven neat organic solvents ranged from 278.15 K to 318.15 K. J. Mol. Liq. 2022, 348, 118184. [Google Scholar] [CrossRef]
  20. Kitak, T.; Dumicic, A.; Planinsek, O.; Sibanc, R.; Srcic, S. Determination of solubility parameters of ibuprofen and ibuprofen lysinate. Molecules 2015, 20, 21549–21568. [Google Scholar] [CrossRef]
  21. Zhang, C.; Jouyban, A.; Zhao, H.; Farajtabar, A.; Acree, W.E., Jr. Equilibrium solubility, Hansen solubility parameter, dissolution thermodynamics, transfer property and preferential solvation of zonisamide in aqueous binary mixtures of ethanol, acetonitrile, isopropanol and N,N-dimethylformamide. J. Mol. Liq. 2021, 326, 115219. [Google Scholar] [CrossRef]
  22. He, H.; Wan, Y.; Sun, R.; Zhang, P.; Jiang, G.; Sha, J.; Li, Y.; Li, T.; Ren, B. Piperonylonitrile solubility in thirteen pure solvents: Correlation, Hansen solubility parameters solvent effect and thermodynamic analysis. J. Chem. Thermodyn. 2020, 150, 106191. [Google Scholar] [CrossRef]
  23. Van Krevelen, D.W.; Te Nijenhuis, K. Properties of Polymers: Their Correlation with Chemical Structure; Their Numerical Estimation and Prediction from Additive Group Contributions; Elsevier: Amsterdam, The Netherlands, 2009; p. 189. [Google Scholar]
  24. Güner, A. The algorithmic calculations of solubility parameter for the determination of interactions in dextran/certain polar solvent systems. Eur. Polym. J. 2004, 40, 1587–1594. [Google Scholar] [CrossRef]
  25. Mohammad, M.A.; Alhalaweh, A.; Velaga, S.P. Hansen solubility parameter as a tool to predict cocrystal formation. Int. J. Pharm. 2011, 407, 63–71. [Google Scholar] [CrossRef] [PubMed]
  26. Chen, J.; Zhao, H.; Farajtabar, A.; Zhu, P.; Jouyban, A.; Acree, W.E., Jr. Equilibrium solubility of amrinone in aqueous co-solvent solutions reconsidered: Quantitative molecular surface, inter/intra-molecular interactions and solvation thermodynamics analysis. J. Mol. Liq. 2022, 355, 118995. [Google Scholar] [CrossRef]
  27. Greenhalgh, D.J.; Williams, A.C.; Timmins, P.; York, P. Solubility parameters as predictors of miscibility in solid dispersions. J. Pharm. Sci. 1999, 88, 1182–1190. [Google Scholar] [CrossRef] [PubMed]
  28. Tinjaca, D.A.; Martinez, F.; Almanza, O.A.; Jouyban, A.; Acree, W.E. Solubility, correlation, dissolution thermodynamics and preferential solvation of meloxicam in aqueous mixtures of 2-propanol. Pharm. Sci. 2022, 28, 130–144. [Google Scholar] [CrossRef]
  29. Hildebrand, J.H.; Prausnitz, J.M.; Scott, R.L. Regular and Related Solutions; Van Nostrand Reinhold: New York, NY, USA, 1970. [Google Scholar]
  30. Manrique, Y.J.; Pacheco, D.P.; Martínez, F. Thermodynamics of mixing and solvation of ibuprofen and naproxen in propylene glycol + water cosolvent mixtures. J. Sol. Chem. 2008, 37, 165–181. [Google Scholar] [CrossRef]
  31. Zhang, Y.; Shi, X.; Yu, Y.; Zhao, S.; Song, H.; Chen, A.; Shang, Z. Preparation and characterization of vanillin cross-linked chitosan microspheres of pterostilbene. Int. J. Polym. Anal. Charact. 2014, 19, 83–93. [Google Scholar] [CrossRef]
  32. Mohammadian, E.; Rahimpour, E.; Martinez, F.; Jouyban, A. Budesonide solubility in polyethylene glycol 400 + water at different temperatures: Experimental measurement and mathematical modelling. J. Mol. Liq. 2019, 274, 418–425. [Google Scholar] [CrossRef]
  33. Apelblat, A.; Manzurola, E. Solubilities of o-acetylsalicylic, 4-aminosalicylic, 3,5-dinitrosalicylic and p-toluic acid and magnesium-DL-aspartate in water from T = (278–348) K. J. Chem. Thermodyn. 1999, 31, 85–91. [Google Scholar] [CrossRef]
  34. Manzurola, E.; Apelblat, A. Solubilities of L-glutamic acid, 3-nitrobenzoic acid, acetylsalicylic, p-toluic acid, calcium-L-lactate, calcium gluconate, magnesium-DL-aspartate, and magnesium-L-lactate in water. J. Chem. Thermodyn. 2002, 34, 1127–1136. [Google Scholar] [CrossRef]
  35. Ksiazczak, A.; Moorthi, K.; Nagata, I. Solid-solid transition and solubility of even n-alkanes. Fluid Phase Equilib. 1994, 95, 15–29. [Google Scholar] [CrossRef]
  36. Tong, Y.; Wang, Z.; Yang, E.; Pan, B.; Jiang, J.; Dang, P.; Wei, H. Determination and correlation of solubility and solution thermodynamics of ethenzamide in different pure solvents. Fluid Phase Equilib. 2016, 427, 549–556. [Google Scholar] [CrossRef]
  37. Shakeel, F.; Alshehri, S. Solubilization, Hansen solubility parameters, solution thermodynamics and solvation behavior of flufenamic acid in (Carbitol + water) mixtures. Processes 2020, 8, 1204. [Google Scholar] [CrossRef]
  38. Krug, R.R.; Hunter, W.G.; Grieger, R.S. Enthalpy-entropy compensation. 2. Separation of the chemical from the statistic effect. J. Phys. Chem. 1976, 80, 2341–2351. [Google Scholar] [CrossRef]
  39. Holguín, A.R.; Rodríguez, G.A.; Cristancho, D.M.; Delgado, D.R.; Martínez, F. Solution thermodynamics of indomethacin in propylene glycol + water mixtures. Fluid Phase Equilib. 2012, 314, 134–139. [Google Scholar] [CrossRef]
  40. Chen, J.; Farajtabar, A.; Jouyban, A.; Acree, W.E., Jr.; Zhao, H. Solubility, three-dimensional Hansen solubility parameters, and solution thermodynamics of 3,3′-diaminodiphenyl sulfone in 14 neat solvents from 283.15 to 328.15 K. J. Chem. Eng. Data 2021, 66, 2167–2176. [Google Scholar] [CrossRef]
  41. Martinez, F.; Jouyban, A.; Acree, W.E., Jr. Equilibrium solubility of trans-resveratrol in {acetone (1) + water (2)} mixtures: Correlation, dissolution thermodynamics and preferential solvation. Phys. Chem. Liq. 2022, 60, 598–615. [Google Scholar] [CrossRef]
Figure 1. Molecular structure of febuxostat (FBX).
Figure 1. Molecular structure of febuxostat (FBX).
Molecules 27 04043 g001
Figure 2. van’t Hoff plots for FBX plotted between ln xe and 1/T − 1/Thm for FBX in different mono solvents.
Figure 2. van’t Hoff plots for FBX plotted between ln xe and 1/T − 1/Thm for FBX in different mono solvents.
Molecules 27 04043 g002
Figure 3. Fourier transforms infra-red (FTIR) spectra of (A) pure FBX and (B) equilibrated FBX recovered from water.
Figure 3. Fourier transforms infra-red (FTIR) spectra of (A) pure FBX and (B) equilibrated FBX recovered from water.
Molecules 27 04043 g003
Figure 4. Powder X-ray diffraction (PXRD) spectra of (A) pure FBX and (B) equilibrated FBX recovered from water.
Figure 4. Powder X-ray diffraction (PXRD) spectra of (A) pure FBX and (B) equilibrated FBX recovered from water.
Molecules 27 04043 g004
Figure 5. Comparison of mole fraction solubility values of FBX in (A) MeOH, (B) EtOH, and (C) EA with literature values at 298.2–318.2 K; the symbol Molecules 27 04043 i001 indicates the experimental mole fraction solubilities of FBX in (A) MeOH, (B) EtOH, and (C) EA and the symbol Molecules 27 04043 i002 indicates the literature solubilities of FBX in (A) MeOH, (B) EtOH, and (C) EA taken from reference [1].
Figure 5. Comparison of mole fraction solubility values of FBX in (A) MeOH, (B) EtOH, and (C) EA with literature values at 298.2–318.2 K; the symbol Molecules 27 04043 i001 indicates the experimental mole fraction solubilities of FBX in (A) MeOH, (B) EtOH, and (C) EA and the symbol Molecules 27 04043 i002 indicates the literature solubilities of FBX in (A) MeOH, (B) EtOH, and (C) EA taken from reference [1].
Molecules 27 04043 g005
Figure 6. Correlation of experimental FBX solubilities with the “Apelblat model” in several mono solvents as a function of 1/T; symbols denote the experimental FBX solubility data, whereas solid lines denote the “Apelblat model” FBX solubility data.
Figure 6. Correlation of experimental FBX solubilities with the “Apelblat model” in several mono solvents as a function of 1/T; symbols denote the experimental FBX solubility data, whereas solid lines denote the “Apelblat model” FBX solubility data.
Molecules 27 04043 g006
Table 1. Experimental solubilities (xe) and ideal solubilities (xidl) of febuxostat (FBX) in mole fraction in various mono solvents (MS) at 298.2–318.2 K and 101.1 kPa a.
Table 1. Experimental solubilities (xe) and ideal solubilities (xidl) of febuxostat (FBX) in mole fraction in various mono solvents (MS) at 298.2–318.2 K and 101.1 kPa a.
MSxe
T = 298.2 KT = 303.2 KT = 308.2 KT = 313.2 KT = 318.2 K
Water1.94 × 10−73.30 × 10−75.12 × 10−77.40 × 10−71.14 × 10−6
EG6.07 × 10−47.64 × 10−49.01 × 10−41.05 × 10−31.31 × 10−3
PG8.26 × 10−49.61 × 10−41.15 × 10−31.39 × 10−31.88 × 10−3
MeOH8.15 × 10−41.14 × 10−31.63 × 10−32.32 × 10−33.26 × 10−3
EtOH1.73 × 10−32.65 × 10−33.98 × 10−35.81 × 10−38.37 × 10−3
IPA2.29 × 10−33.55 × 10−35.29 × 10−37.72 × 10−31.10 × 10−2
1-BuOH2.89 × 10−34.47 × 10−36.67 × 10−39.67 × 10−31.37 × 10−2
2-BuOH2.94 × 10−34.54 × 10−36.74 × 10−39.78 × 10−31.38 × 10−2
DMSO2.95 × 10−33.69 × 10−34.67 × 10−35.89 × 10−37.35 × 10−3
EA4.57 × 10−35.15 × 10−36.36 × 10−37.35 × 10−38.31 × 10−3
THP6.37 × 10−38.46 × 10−31.09 × 10−21.38 × 10−21.70 × 10−2
PEG-4009.92 × 10−31.24 × 10−21.73 × 10−22.34 × 10−23.06 × 10−2
xidl3.55 × 10−23.97 × 10−24.44 × 10−24.96 × 10−25.52 × 10−2
a The relative uncertainties ur are ur (T) = 0.011, ur (p) = 0.003 and ur (xe) = 0.013.
Table 2. Different solubility parameters of FBX and several MS at 298.2 K.
Table 2. Different solubility parameters of FBX and several MS at 298.2 K.
ComponentsHansen Solubility ParametersRa */MPa1/2δ/MPa1/2δ */MPa1/2
δd/MPa1/2δp/MPa1/2δh/MPa1/2δ/MPa1/2
FBX19.307.206.9021.70---
Water15.5016.0042.3047.8037.2636.6726.10
EG18.0011.1023.4031.6017.1517.009.90
PG17.409.1021.7029.2015.3915.047.50
MeOH17.4010.6022.4030.3016.3115.988.60
EtOH16.208.4017.6025.4012.4211.203.70
IPA15.806.6014.3022.3010.248.250.60
1-BuOH15.906.3015.2022.9010.769.011.20
2-BuOH15.805.4012.4020.809.086.761.10
DMSO17.4014.207.3023.607.977.261.90
EA15.705.607.0018.107.373.943.60
THP16.307.2011.9021.407.815.830.30
PEG-40014.607.509.4018.909.735.332.80
* These values were calculated between FBX and respective mono solvents.
Table 3. Activity coefficients (γi) of FBX in several MS at 298.2–318.2 K.
Table 3. Activity coefficients (γi) of FBX in several MS at 298.2–318.2 K.
MSγi
T = 298.2 KT = 303.2 KT = 308.2 KT = 313.2 KT = 318.2 K
Water183,447120,44686,780.267,045.248,549.3
EG58.431252.028449.322946.895342.1173
PG42.988341.388938.568235.628232.8967
MeOH43.546334.800027.151921.356716.9578
EtOH20.524414.970411.15258.529616.60309
IPA15.478611.17818.405596.421795.00518
1-BuOH12.25478.883156.658715.129744.01502
2-BuOH12.06088.747106.590285.069553.98862
DMSO12.020110.77839.522678.423307.51820
EA7.764387.718986.987426.749066.65091
THP5.575444.701764.077843.595933.23515
PEG-4003.577863.186032.556992.115631.80452
Table 4. Apelblat model results for FBX in several MS in terms of model parameters (A, B and C), R2, and root mean square deviation (RMSD).
Table 4. Apelblat model results for FBX in several MS in terms of model parameters (A, B and C), R2, and root mean square deviation (RMSD).
MSA ± SDB ± SDC ± SDR2Overall RMSD (%)
Water744.41 ± 5.9712−41,890 ± 114.24−108.70 ± 2.54780.9983
EG−33.013 ± 1.1102−1829.9 ± 7.84105.5734 ± 0.421400.9959
PG−493.76 ± 3.841219,451 ± 44.12173.966 ± 2.23100.9996
MeOH−270.82 ± 2.64106494.8 ± 52.31042.461 ± 2.31010.9999
EtOH323.16 ± 3.2015−21,470 ± 94.311−45.198 ± 2.48700.9999
IPA437.02 ± 3.9104−26,654 ± 98.410−62.082 ± 2.52010.99991.14
1-BuOH480.91 ± 4.0951−28,607 ± 102.02−68.594 ± 2.28100.9999
2-BuOH502.88 ± 2.0463−29,579 ± 104.17−71.876 ± 2.84130.9999
DMSO−177.93 ± 1.980442,067 ± 118.3027.730 ± 1.02340.9998
EA57.412 ± 1.2400−5381.8 ± 101.33−7.8569 ± 0.531010.9919
THP460.89 ± 4.0121−25,357 ± 91.142−66.855 ± 2.32800.9999
PEG-400−460.19 ± 3.990416,261 ± 94.21570.385 ± 2.71050.9976
Table 5. van’t Hoff model results for FBX in several MS in terms of model parameters (a and b), R2, and RMSD.
Table 5. van’t Hoff model results for FBX in several MS in terms of model parameters (a and b), R2, and RMSD.
MSa ± SDb ± SDR2Overall RMSD (%)
Water12.295 ± 1.1024−8264.2 ± 24.1610.9974
EG4.4757 ± 0.20190−3539.9 ± 15.4110.9959
PG4.2711 ± 0.18020−3396.5 ± 14.0530.9964
MeOH15.023 ± 1.1200−6604.7 ± 21.4120.9996
EtOH18.718 ± 1.1304−7475.1 ± 23.0580.9998
IPA18.890 ± 1.1322−7440.7 ± 22.9400.99961.60
1-BuOH18.926 ± 1.1318−7381.5 ± 22.6640.9995
2-BuOH18.801 ± 1.1250−7339.3 ± 22.4600.9994
DMSO8.7471 ± 0.44010−4347.9 ± 17.1840.9996
EA4.4720 ± 0.19040−2943.3 ± 12.4110.9920
THP10.648 ± 1.0641−4778.4 ± 18.7220.9988
PEG-40013.707 ± 1.1200−5472.1 ± 20.0220.9965
Table 6. Buchowski-Ksiazaczak λh model results for FBX in numerous MS.
Table 6. Buchowski-Ksiazaczak λh model results for FBX in numerous MS.
MSλ ± SDh ± SDOverall RMSD (%)
Water3.6910 ± 0.110002238.9 ± 10.801
EG1.8000 ± 0.07001966.6 ± 9.8104
PG1.7100 ± 0.061001986.2 ± 9.9420
MeOH0.44800 ± 0.0310014742 ± 8.1200
EtOH2.3539 ± 0.092003175.5 ± 13.710
IPA2.5966 ± 0.101002865.5 ± 12.8402.86
1-BuOH2.7544 ± 0.103002679.8 ± 11.510
2-BuOH2.7161 ± 0.102102702.1 ± 11.940
DMSO−0.81040 ± 0.04100−5365.1 ± 19.120
EA0.57760 ± 0.030005095.7 ± 18.052
THP0.03210 ± 0.00000145,744 ± 128.514
PEG-4001.4601 ± 0.051013747.7 ± 14.501
Table 7. Apparent thermodynamic parameters (ΔsolH0, ΔsolG0, and ΔsolS0) along with R2 values for FBX in numerous MS a.
Table 7. Apparent thermodynamic parameters (ΔsolH0, ΔsolG0, and ΔsolS0) along with R2 values for FBX in numerous MS a.
MSΔsolH0/kJ mol−1ΔsolG0/kJ mol−1ΔsolS0/J mol−1 K−1R2
Water68.7937.21102.50.9973
EG29.4617.9637.340.9958
PG28.2717.2935.640.9966
MeOH54.9816.43125.10.9996
EtOH62.2314.20155.90.9997
IPA61.9413.47157.30.9995
1-BuOH61.4512.89157.60.9994
2-BuOH61.1012.86156.50.9994
DMSO36.1913.7472.890.9996
EA24.5013.0137.300.9921
THP38.9411.6288.700.9987
PEG-40045.5610.38114.10.9966
a The relative uncertainties are usolH0) = 0.033, usolG0) = 0.044 and usolS0) = 0.047.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Haq, N.; Alghaith, A.F.; Alshehri, S.; Shakeel, F. Solubility and Thermodynamic Data of Febuxostat in Various Mono Solvents at Different Temperatures. Molecules 2022, 27, 4043. https://doi.org/10.3390/molecules27134043

AMA Style

Haq N, Alghaith AF, Alshehri S, Shakeel F. Solubility and Thermodynamic Data of Febuxostat in Various Mono Solvents at Different Temperatures. Molecules. 2022; 27(13):4043. https://doi.org/10.3390/molecules27134043

Chicago/Turabian Style

Haq, Nazrul, Adel F. Alghaith, Sultan Alshehri, and Faiyaz Shakeel. 2022. "Solubility and Thermodynamic Data of Febuxostat in Various Mono Solvents at Different Temperatures" Molecules 27, no. 13: 4043. https://doi.org/10.3390/molecules27134043

Article Metrics

Back to TopTop